+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Health for Obesity - Global Strategic Business Report

  • PDF Icon

    Report

  • 281 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6069970
The global market for Digital Health for Obesity was estimated at US$49.7 Billion in 2025 and is projected to reach US$195.9 Billion by 2032, growing at a CAGR of 21.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Digital Health for Obesity Market - Key Trends & Drivers Summarized

Can AI-Powered Health Apps Tackle the Global Obesity Epidemic?

The global obesity crisis is being addressed through the rapid adoption of AI-powered digital health solutions that offer personalized weight management programs. Traditional weight loss approaches often fail due to a lack of personalization, accountability, and long-term behavioral support. Digital health applications are now integrating AI-driven meal planning, metabolic tracking, and behavioral coaching to create adaptive weight loss programs tailored to individual needs. AI algorithms analyze users’ dietary habits, physical activity levels, and metabolic responses to provide customized nutrition and fitness recommendations. Additionally, digital coaching platforms such as Noom and Lark use AI-powered chatbots to provide real-time motivation and adherence support. While these solutions enhance accessibility and personalization, concerns regarding the accuracy of AI-driven recommendations and the long-term sustainability of digital weight management strategies remain. Nevertheless, as AI-driven health coaching continues to advance, it is expected to play a critical role in combating obesity, reducing healthcare costs, and improving public health outcomes.

How Is Remote Monitoring Enhancing Weight Management?

The integration of remote monitoring tools in obesity management is significantly improving patient outcomes by enabling continuous tracking of vital health metrics such as weight fluctuations, calorie intake, and physical activity levels. Wearable fitness trackers and smart scales connected to mobile applications allow users to monitor their progress in real-time, promoting adherence to weight loss programs. Continuous glucose monitoring (CGM) technology is also emerging as a key component of personalized obesity management, providing insights into how different foods affect blood sugar levels and metabolic responses. Telehealth services are further enhancing access to obesity care by connecting patients with nutritionists, endocrinologists, and behavioral therapists remotely. However, while remote monitoring solutions provide valuable data-driven insights, challenges such as user engagement retention, data privacy, and device affordability still need to be addressed. As technology improves and remote health monitoring becomes more seamless, digital solutions for obesity management are expected to become increasingly effective, paving the way for more sustainable weight loss outcomes.

Are Digital Therapeutics (DTx) the Future of Obesity Treatment?

Digital therapeutics (DTx) are emerging as an evidence-based approach to treating obesity by addressing behavioral, psychological, and physiological factors contributing to weight gain. Unlike traditional diet apps, DTx solutions are clinically validated and designed to provide structured interventions for weight loss, often incorporating behavioral modification techniques such as cognitive behavioral therapy (CBT) and habit-tracking algorithms. AI-powered metabolic health platforms, such as Virta Health, use continuous patient data to optimize dietary interventions, improving long-term weight loss success rates. Additionally, virtual coaching programs and mobile-based interventions are being integrated with weight-loss medications to enhance adherence and improve efficacy. Despite the potential of DTx in obesity management, regulatory approvals, reimbursement policies, and long-term efficacy studies remain key hurdles. However, as more clinical evidence supports the effectiveness of digital obesity treatments, adoption is expected to grow, leading to a paradigm shift in obesity care.

What Is Driving the Growth of the Digital Health for Obesity Market?

The growth in the digital health for obesity market is driven by several key factors, including increasing obesity prevalence, rising healthcare costs, and advancements in AI-driven weight management solutions. The adoption of wearable health devices and mobile health applications is making personalized weight management more accessible and scalable. The expansion of telehealth services and virtual coaching programs is improving patient engagement, reducing the need for in-person consultations. The integration of AI, behavioral science, and data analytics is enabling more effective, individualized weight-loss interventions. Regulatory support for digital therapeutics and increasing insurance coverage for digital weight management programs are further driving market adoption. Additionally, growing investment in digital health startups specializing in metabolic health is accelerating innovation in obesity care. As obesity rates continue to rise globally, digital health solutions are expected to play a crucial role in providing cost-effective, scalable, and evidence-based interventions for sustainable weight management.

Report Scope

The report analyzes the Digital Health for Obesity market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Component (Software Component, Hardware Component, Services); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Software Component segment, which is expected to reach US$100.1 Billion by 2032 with a CAGR of 19.4%. The Hardware Component segment is also set to grow at 24.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $15.4 Billion in 2025, and China, forecasted to grow at an impressive 28.0% CAGR to reach $53.4 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Digital Health for Obesity Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Digital Health for Obesity Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Digital Health for Obesity Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Calibrate, DarioHealth, Daphne Platform, Digital Therapeutics Alliance, Eli Lilly and Company and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Digital Health for Obesity market report include:

  • Calibrate
  • DarioHealth
  • Daphne Platform
  • Digital Therapeutics Alliance
  • Eli Lilly and Company
  • Fitbit
  • Form Health
  • Found
  • Hinge Health
  • Kurbo Health
  • Lark Health
  • Noom
  • Omada Health
  • Ro
  • Soleno Therapeutics
  • Teladoc Health
  • Vida Health
  • WW International
  • Xenetic Biosciences

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Digital Health for Obesity - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Global Prevalence of Obesity Drives Demand for Digital Health Solutions in Weight Management
  • Surge in Consumer Focus on Health and Wellness Expands Addressable Market for Digital Health Tools Targeting Obesity
  • Technological Advancements in Wearable Devices and Health Monitoring Tools Strengthen the Business Case for Digital Obesity Solutions
  • The Rise of Mobile Health Apps and Virtual Weight Loss Coaching Accelerates Adoption of Digital Health for Obesity
  • Increasing Investment in Preventive Healthcare and Wellness Programs Propels Demand for Digital Obesity Management Solutions
  • Growing Acceptance of Telemedicine and Remote Health Consultations Expands Opportunities for Digital Obesity Solutions
  • Integration of Artificial Intelligence and Machine Learning in Digital Health Tools Enhances Personalization of Obesity Treatment Plans
  • Increasing Awareness of the Link Between Obesity and Chronic Diseases Drives Adoption of Digital Solutions for Comprehensive Health Management
  • Surge in Corporate Wellness Programs and Employer-Sponsored Health Initiatives Creates Market Opportunities for Digital Obesity Solutions
  • Expansion of Personalized Medicine and Tailored Weight Management Programs Strengthens the Case for Digital Health Tools in Obesity Care
  • Growing Focus on Behavioral Health and Mental Wellness Drives Adoption of Digital Health Solutions for Emotional and Psychological Aspects of Obesity
  • Rise in Consumer Demand for Data-Driven Health Insights Accelerates Growth in Digital Health Platforms for Obesity Monitoring
  • Regulatory Support and Incentives for Digital Therapeutics in Obesity Management Generate Confidence in Digital Health Solutions
  • The Growth of Virtual and Remote Weight Loss Support Communities Strengthens Market Demand for Digital Health Solutions in Obesity Care
  • Increasing Role of Digital Therapeutics and FDA-Approved Apps for Obesity Expands Market Reach and Credibility
  • Growing Focus on Preventative Measures in Obesity and Lifestyle Diseases Strengthens the Demand for Early-Intervention Digital Health Tools
  • Surge in Adoption of Digital Health for Pediatric Obesity Management Expands Addressable Market for Youth-Focused Weight Management Tools
  • Rising Popularity of Nutritional Genomics and Personalized Diet Plans Propels Demand for Digital Health Tools Integrating Genetic Data in Obesity Treatment
  • Integration of Cross-Platform Solutions for Holistic Health Management Expands Opportunities for Digital Obesity Solutions in Broader Health Ecosystems
  • Increasing Healthcare Provider and Payer Investment in Digital Health Solutions for Obesity Treatment Strengthens Long-Term Market Adoption
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Digital Health for Obesity Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Digital Health for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Digital Health for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Digital Health for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 29: USA Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 30: USA Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: USA 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 35: Canada Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 36: Canada Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: Canada 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
JAPAN
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 41: Japan Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 42: Japan Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: Japan 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CHINA
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 47: China Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 48: China Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: China 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
EUROPE
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Digital Health for Obesity by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Digital Health for Obesity by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Digital Health for Obesity by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 56: Europe Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: Europe Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: Europe 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
FRANCE
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 62: France Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: France Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 64: France 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
GERMANY
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 68: Germany Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 69: Germany Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 70: Germany 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 74: Italy Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 75: Italy Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 76: Italy 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 80: UK Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 81: UK Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 82: UK 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SPAIN
  • Table 83: Spain Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 86: Spain Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 87: Spain Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 88: Spain 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
RUSSIA
  • Table 89: Russia Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 92: Russia Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 93: Russia Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 94: Russia 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Obesity by Component - Software Component, Hardware Component and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Digital Health for Obesity by Component - Software Component, Hardware Component and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Digital Health for Obesity by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services for the Years 2020, 2026 & 2032
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 99: Rest of Europe Historic Review for Digital Health for Obesity by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 100: Rest of Europe 13-Year Perspective for Digital Health for Obesity by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AUSTRALIA
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
  • Digital Health for Obesity Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Calibrate
  • DarioHealth
  • Daphne Platform
  • Digital Therapeutics Alliance
  • Eli Lilly and Company
  • Fitbit
  • Form Health
  • Found
  • Hinge Health
  • Kurbo Health
  • Lark Health
  • Noom
  • Omada Health
  • Ro
  • Soleno Therapeutics
  • Teladoc Health
  • Vida Health
  • WW International
  • Xenetic Biosciences

Table Information